Mapping genomic loci prioritises genes and implicates synaptic biology in schizophrenia

Schizophrenia has a heritability of 60–80%1, much of which is attributable to common risk alleles. Here, in a two-stage genome-wide association study of up to 76,755 individuals with schizophrenia and 243,649 control individuals, we report common variant associations at 287 distinct genomic loci. Associations were concentrated in genes that are expressed in excitatory and inhibitory neurons of the central nervous system, but not in other tissues or cell types. Using fine-mapping and functional genomic data, we identify 120 genes (106 protein-coding) that are likely to underpin associations at some of these loci, including 16 genes with credible causal non-synonymous or untranslated region variation. We also implicate fundamental processes related to neuronal function, including synaptic organization, differentiation and transmission. Fine-mapped candidates were enriched for genes associated with rare disruptive coding variants in people with schizophrenia, including the glutamate receptor subunit GRIN2A and transcription factor SP4, and were also enriched for genes implicated by such variants in neurodevelopmental disorders. We identify biological processes relevant to schizophrenia pathophysiology; show convergence of common and rare variant associations in schizophrenia and neurodevelopmental disorders; and provide a resource of prioritized genes and variants to advance mechanistic studies

Genomic Dissection of Bipolar Disorder and Schizophrenia, Including 28 Subphenotypes

Schizophrenia and bipolar disorder are two distinct diagnoses that share symptomology. Understanding the genetic factors contributing to the shared and disorder-specific symptoms will be crucial for improving diagnosis and treatment. In genetic data consisting of 53,555 cases (20,129 bipolar disorder [BD], 33,426 schizophrenia [SCZ]) and 54,065 controls, we identified 114 genome-wide significant loci implicating synaptic and neuronal pathways shared between disorders. Comparing SCZ to BD (23,585 SCZ, 15,270 BD) identified four genomic regions including one with disorder-independent causal variants and potassium ion response genes as contributing to differences in biology between the disorders. Polygenic risk score (PRS) analyses identified several significant correlations within case-only phenotypes including SCZ PRS with psychotic features and age of onset in BD. For the first time, we discover specific loci that distinguish between BD and SCZ and identify polygenic components underlying multiple symptom dimensions. These results point to the utility of genetics to inform symptomology and potential treatment

Biological insights from 108 schizophrenia-associated genetic loci

Schizophrenia is a highly heritable disorder. Genetic risk is conferred by a large number of alleles, including common alleles of small effect that might be detected by genome-wide association studies. Here we report a multi-stage schizophrenia genome-wide association study of up to 36,989 cases and 113,075 controls. We identify 128 independent associations spanning 108 conservatively defined loci that meet genome-wide significance, 83 of which have not been previously reported. Associations were enriched among genes expressed in brain, providing biological plausibility for the findings. Many findings have the potential to provide entirely new insights into aetiology, but associations at DRD2 and several genes involved in glutamatergic neurotransmission highlight molecules of known and potential therapeutic relevance to schizophrenia, and are consistent with leading pathophysiological hypotheses. Independent of genes expressed in brain, associations were enriched among genes expressed in tissues that have important roles in immunity, providing support for the speculated link between the immune system and schizophrenia

Genome-wide Association Study Identifies SESTD1 as a Novel Risk Gene for Lithium Responsive Bipolar Disorder

Lithium is the mainstay prophylactic treatment for bipolar disorder (BD), but treatment response varies considerably across individuals. Patients who respond well to lithium treatment might represent a relatively homogeneous subtype of this genetically and phenotypically diverse disorder. Here, we performed genome-wide association studies (GWAS) to identify (i) specific genetic variations influencing lithium response and (ii) genetic variants associated with risk for lithium-responsive BD. Patients with BD and controls were recruited from Sweden and the United Kingdom. GWAS were performed on 2698 patients with subjectively defined (self-reported) lithium response and 1176 patients with objectively defined (clinically documented) lithium response. We next conducted GWAS comparing lithium responders with healthy controls (1639 subjective responders and 8899 controls; 323 objective responders and 6684 controls). Meta-analyses of Swedish and UK results revealed no significant associations with lithium response within the bipolar subjects. However, when comparing lithium-responsive patients with controls, two imputed markers attained genome-wide significant associations, among which one was validated in confirmatory genotyping (rs116323614, P=2.74 × 10-8). It is an intronic single-nucleotide polymorphism (SNP) on chromosome 2q31.2 in the gene SEC14 and spectrin domains 1 (SESTD1), which encodes a protein involved in regulation of phospholipids. Phospholipids have been strongly implicated as lithium treatment targets. Furthermore, we estimated the proportion of variance for lithium-responsive BD explained by common variants ('SNP heritability') as 0.25 and 0.29 using two definitions of lithium response. Our results revealed a genetic variant in SESTD1 associated with risk for lithium-responsive BD, suggesting that the understanding of BD etiology could be furthered by focusing on this subtype of BD

LD Score regression distinguishes confounding from polygenicity in genome-wide association studies

Both polygenicity (many small genetic effects) and confounding biases, such as cryptic relatedness and population stratification, can yield an inflated distribution of test statistics in genome-wide association studies (GWAS). However, current methods cannot distinguish between inflation from a true polygenic signal and bias. We have developed an approach, LD Score regression, that quantifies the contribution of each by examining the relationship between test statistics and linkage disequilibrium (LD). The LD Score regression intercept can be used to estimate a more powerful and accurate correction factor than genomic control. We find strong evidence that polygenicity accounts for the majority of the inflation in test statistics in many GWAS of large sample size

Biological insights from 108 schizophrenia-associated genetic loci

Schizophrenia is a highly heritable disorder. Genetic risk is conferred by a large number of alleles, including common alleles of small effect that might be detected by genome-wide association studies. Here we report a multi-stage schizophrenia genome-wide association study of up to 36,989 cases and 113,075 controls. We identify 128 independent associations spanning 108 conservatively defined loci that meet genome-wide significance, 83 of which have not been previously reported. Associations were enriched among genes expressed in brain, providing biological plausibility for the findings. Many findings have the potential to provide entirely new insights into aetiology, but associations at DRD2 and several genes involved in glutamatergic neurotransmission highlight molecules of known and potential therapeutic relevance to schizophrenia, and are consistent with leading pathophysiological hypotheses. Independent of genes expressed in brain, associations were enriched among genes expressed in tissues that have important roles in immunity, providing support for the speculated link between the immune system and schizophrenia

Contribution of copy number variants to schizophrenia from a genome-wide study of 41,321 subjects

Copy number variants (CNVs) have been strongly implicated in the genetic etiology of schizophrenia (SCZ). However, genome-wide investigation of the contribution of CNV to risk has been hampered by limited sample sizes. We sought to address this obstacle by applying a centralized analysis pipeline to a SCZ cohort of 21,094 cases and 20,227 controls. A global enrichment of CNV burden was observed in cases (odds ratio (OR) = 1.11, P = 5.7 x 10(-15)), which persisted after excluding loci implicated in previous studies (OR = 1.07, P = 1.7 x 10(-6)). CNV burden was enriched for genes associated with synaptic function (OR = 1.68, P = 2.8 x 10(-11)) and neurobehavioral phenotypes in mouse (OR = 1.18, P = 7.3 x 10(-5)). Genome-wide significant evidence was obtained for eight loci, including 1q21.1, 2p16.3 (NRXN1), 3q29, 7q11.2, 15q13.3, distal 16p11.2, proximal 16p11.2 and 22q11.2. Suggestive support was found for eight additional candidate susceptibility and protective loci, which consisted predominantly of CNVs mediated by nonallelic homologous recombination

Biological insights from 108 schizophrenia-associated genetic loci

Schizophrenia is a highly heritable disorder. Genetic risk is conferred by a large number of alleles, including common alleles of small effect that might be detected by genome-wide association studies. Here we report a multi-stage schizophrenia genome-wide association study of up to 36,989 cases and 113,075 controls. We identify 128 independent associations spanning 108 conservatively defined loci that meet genome-wide significance, 83 of which have not been previously reported. Associations were enriched among genes expressed in brain, providing biological plausibility for the findings. Many findings have the potential to provide entirely new insights into aetiology, but associations at DRD2 and several genes involved in glutamatergic neurotransmission highlight molecules of known and potential therapeutic relevance to schizophrenia, and are consistent with leading pathophysiological hypotheses. Independent of genes expressed in brain, associations were enriched among genes expressed in tissues that have important roles in immunity, providing support for the speculated link between the immune system and schizophrenia

Литература о Свердловской области: [указатель]. 1954. Вып. 3-4

0|5|Предисловие [c. 5]0|6|Схема классификации летописи литературы о Свердловской области [c. 6]0|9|Коммунистическая партия Советского Союза [c. 9]1|9|Партийное строительство. Руководство партии хозяйственным и культурным строительством [c. 9]1|15|Пропаганда и агитация. Партийное просвещение [c. 15]1|17|История Коммунистической партии Советского Союза [c. 17]0|18|ВЛКСМ. [c. 18]0|21|Пионерские организации и внешкольная работа [c. 21]0|22|История гор. Свердловска и Свердловской области [c. 22]0|23|Социалистическое строительство в Свердловской области [c. 23]0|23|Финансы [c. 23]0|24|Труд [c. 24]1|26|Профессиональные союзы [c. 26]1|27|Социалистическое соревнование. Общие материалы [c. 27]1|28|Соревнование городов [c. 28]0|28|Советское строительство [c. 28]1|28|Выборы в Верховный Совет РСФСР [c. 28]1|28|Местные органы государственной власти [c. 28]1|29|Органы юстиции. Суд и прокуратура [c. 29]0|31|Природа Свердловской области [c. 31]1|31|Геология. Палеонтология. Археология [c. 31]1|32|География [c. 32]1|32|Животный и растительный мир [c. 32]0|32|Техника. Промышленность [c. 32]1|32|История техники и промышленности [c. 32]1|33|Общие вопросы [c. 33]1|34|Производство предметов народного потребления [c. 34]1|35|Строительство. Строительные материалы. Строительная промышленность [c. 35]1|35|Строительство заводов железобетонных изделий [c. 35]1|40|Энергетическая промышленность [c. 40]1|41|Горная промышленность [c. 41]1|44|Металлургическая промышленность [c. 44]1|51|Машиностроительная промышленность [c. 51]1|57|Химическая промышленность [c. 57]1|58|Лесная промышленность [c. 58]1|60|Легкая промышленность [c. 60]1|60|Камнерезное дело [c. 60]1|61|Местная и кооперативная промышленность [c. 61]0|62|Транспорт. Связь [c. 62]1|62|Транспорт [c. 62]1|65|Связь [c. 65]0|65|Сельское хозяйство [c. 65]1|65|Свердловская область на сельскохозяйственной выставке [c. 65]1|69|Трудящиеся города — сельскому хозяйству [c. 69]1|70|Общие вопросы. Колхозы. Совхозы [c. 70]1|72|Освоение целинных и залежных земель [c. 72]1|73|Механизация. Электрификация. МТС [c. 73]1|77|Агротехника. Общее растениеводство. Почвоведение [c. 77]1|79|Частное растениеводство [c. 79]2|79|Зерновые и бобовые культуры [c. 79]2|79|Кормовые культуры . Луга. Пастбища [c. 79]2|79|Садоводство. Плодоводство [c. 79]2|80|Овощеводство [c. 80]1|82|Животноводство [c. 82]0|86|Охота. Рыбоводство [c. 86]0|86|Торговля. Общественное питание [c. 86]0|89|Гражданское строительство. Коммунальное хозяйство. Бытовое обслуживание населения [c. 89]0|91|Здравоохранение. Медицина [c. 91]0|92|Физическая культура. Спорт. Игры [c. 92]0|94|Культура. Просвещение. Наука [c. 94]1|94|Общие вопросы культуры и просвещения. Наука [c. 94]1|95|Семья и быт [c. 95]1|96|Дошкольное воспитание [c. 96]1|96|Начальное и среднее образование [c. 96]1|98|Политехническое обучение в школах [c. 98]1|98|Высшее и среднее специальное образование [c. 98]1|101|Ремесленные училища. Фабрично-заводское обучение. Технические училища [c. 101]1|102|Культурно-просветительная работа [c. 102]0|105|Литературоведение. Художественная литература. Фольклор [c. 105]1|105|Литературная критика и библиография [c. 105]1|107|Художественная литература [c. 107]2|107|Проза [c. 107]2|108|Поэзия [c. 108]2|109|Драматургия [c. 109]2|109|Фельетоны [c. 109]0|111|Искусство [c. 111]1|111|Архитектура [c. 111]1|111|Изобразительное искусство [c. 111]1|112|Театр. Зрелищные предприятия [c. 112]1|114|Музыка [c. 114]1|114|Художественная самодеятельность [c. 114]1|115|Кино [c. 115]1|115|Религия. Наука и религия. Атеизм [c. 115]1|116|Печать [c. 116